PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.99%
Negative revenue growth while EXP stands at 21.19%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-89.69%
Negative gross profit growth while EXP is at 41.58%. Joel Greenblatt would examine cost competitiveness or demand decline.
-93.53%
Negative EBIT growth while EXP is at 47.01%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.53%
Negative operating income growth while EXP is at 47.01%. Joel Greenblatt would press for urgent turnaround measures.
-4.08%
Negative net income growth while EXP stands at 45.61%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.08%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.08%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
177.57%
10Y revenue/share CAGR at 75-90% of EXP's 230.85%. Bill Ackman would press for new markets or product lines to narrow the gap.
143.54%
5Y revenue/share CAGR similar to EXP's 153.70%. Walter Schloss might see both companies benefiting from the same mid-term trends.
72.79%
3Y revenue/share CAGR at 50-75% of EXP's 105.30%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Below 50% of EXP's 421.21%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
90.91%
Below 50% of EXP's 191.53%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.